Skip to main content
. Author manuscript; available in PMC: 2011 Jul 18.
Published in final edited form as: Mod Pathol. 2011 Apr 1;24(7):899–907. doi: 10.1038/modpathol.2011.47

Figure 3.

Figure 3

HER2 immunohistochemical staining showing 0 immunostaining (A, ×400), 1+ immunostaining (B, × 400), 2+ immunostaining (C, × 400) and 3+ immunostaining (D, × 400) in esophageal adenocarcinoma. Both 2+ and 3+ uniform staining are considered as HER2 protein overexpression. Incomplete membranous “U” shape stain is presented in B.